Live Breaking News & Updates on Serum Institute Covid 19 Vaccine|Page 1

Stay updated with breaking news from Serum institute covid 19 vaccine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID-19 vaccine: SII, Bharat Biotech to raise production by August


COVID-19 vaccine: SII, Bharat Biotech to raise production by August
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August
BusinessToday.In | May 13, 2021 | Updated 09:33 IST
Serum Institute of India and Bharat Biotech have submitted their production plan for the next four months as several states continue to report the shortages of COVID-19 vaccines.
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August.
Whole-time Director of Bharat Biotech Dr V Krishna Mohan told the Union Health Ministry and the office of Drugs Controller General of India (DCGI) that the production of Covaxin can be raised to 3.32 crore in July and 7.82 crore in August, which will also be maintained in September. ....

Uttar Pradesh , Andhra Pradesh , V Krishna Mohan , Union Health Ministry , Department Of Pharmaceuticals Rajneesh Tingal , While Serum Institute , Serum Institute Of India , Ministry Of Science , Health Ministry Dr Mandeep Bhandari , Serum Institute , Bharat Biotech , Pune Based Serum Institute , Hyderabad Based Bharat Biotech , Bharat Biotech Drv Krishna Mohan , Drugs Controller General , Regulatory Affairs , Serum Institute Prakash Kumar Singh , Joint Secretary , Pharmaceuticals Rajneesh Tingal , Covid 19 Vaccine , Covid 19 Vaccine Production , Serum Institute Of India Covid 19 Vaccine , Bharat Biotech Covid 19 Vaccine , Sii Covid 19 Vaccine , Serum Institute Covid 19 Vaccine , Serum Institute Of Ind ,

SII's Covishield comprises over 90% of 12.76 crore COVID-19 vaccines administered so far


SII s Covishield comprises over 90% of 12.76 crore COVID-19 vaccines administered so far
Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India
PTI | April 21, 2021 | Updated 15:59 IST
Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 127.6 million COVID-19 vaccines administered across the country so far, according to government data on Wednesday. Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India. The other vaccine being administered in India is the indigenous Covaxin from Bharat Biotech in Hyderabad. ....

Jammu And Kashmir , Andhra Pradesh , United Kingdom , Oxford Astrazeneca , Narendra Modi , Indian Council Of Medical Research , Department Of Biotechnology , Pune Based Serum Instiute , Bharat Biotech , Samiran Panda , Communicable Diseases , Indian Council , Medical Research , Minister Narendra Modi , External Affairs Ministers Jaishankar , Covid 19 Vaccines , Covid 19 Vaccination , Covid 19 Vaccines India , Covid 19 Vaccination India , Serum Instiute , Serum Instiute Of India , Sii Covid 19 Vaccine , Serum Institute Covid 19 Vaccine , Covishield Covid 19 Vaccine , Covishield Vaccine Doses , ஜம்மு மற்றும் காஷ்மீர் ,